Adverum BiotechnologiesADVM
13F holders, Q1 2024 (March 31)3holders
$14.14avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Adverum Biotechnologies Inc. (ADVM) in their 13F filings. The largest holders were TCG Crossover Management, LLC ($28.4M), Frazier Life Sciences Management, L.P. ($15.1M) and Versant Venture Management, LLC ($7.2M).
- Company
- Adverum Biotechnologies Inc.
- CUSIP
- 00773U108
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $43.5M |
| Exits | 61 | $44.5M |
Ownership 3 holders
| TCG Crossover Management, LLC | 2.25% | New | 2,008,340 | $28.4M |
| Frazier Life Sciences Management, L.P. | 0.64% | New | 1,069,244 | $15.1M |
| Versant Venture Management, LLC | 6.95% | Reduce -90.0% | 506,822 | $7.2M |
"% of holder's portfolio" is ADVM's weight in each manager's 13F, not the share of Adverum Biotechnologies Inc. the manager owns.